Aspects of the present invention include treating a subject having an acute of chronic central nervous system disorder, such as a brain disorder or spinal cord disorder, by administering an agent that inhibits TREM1 activity and/or expression.
INHIBITION OF TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1 (TREM1) TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS